Please enable JavaScript to continue using this application.

Compare $FHTX vs $VTVT | Chartloom

Compare

$FHTX vs $VTVT

Foghorn Therapeutics Inc · vTv Therapeutics Inc

FHTX

Foghorn Therapeutics Inc

VTVT

vTv Therapeutics Inc

Compare $FHTX vs $VTVT

Comparing Foghorn Therapeutics Inc and vTv Therapeutics Inc

FHTXFoghorn Therapeutics Inc

VTVTvTv Therapeutics Inc

FHTXFoghorn Therapeutics Inc

Market cap

$117M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.04x

Rev growth (TTM)

52.0%

YTD performance

-61.5%

52W performance

-55.6%

FCF yield

-71.8%

VTVTvTv Therapeutics Inc

Market cap

$123M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

216600.0%

YTD performance

-21.3%

52W performance

38.3%

FCF yield

-13.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FHTX

VTVT

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

VTVT

vTv Therapeutics Inc

Market Cap

FHTX$117M

VTVT$123M

Enterprise Value

FHTX$49M

VTVT$36M

Price

FHTX$2.00

VTVT$31.18

P/E Ratio

FHTXN/A

VTVTN/A

P/S Ratio

FHTX3.20x

VTVT3.33x

EV/Sales

FHTX1.34x

VTVT0.98x

EV/EBITDA

FHTX0.00x

VTVT0.00x

P/B Ratio

FHTX1,199.58x

VTVT1.53x

P/FCF Ratio

FHTXN/A

VTVTN/A

EV/FCF

FHTX-0.59x

VTVT-2.16x

PEG Ratio

FHTXN/A

VTVTN/A

Forward P/E (NTM)

FHTXN/A

VTVTN/A

Forward P/S (NTM)

FHTX4.04x

VTVTN/A

Revenue (TTM)

FHTX$37M

VTVT$37M

Revenue Growth (YoY)

FHTX52.0%

VTVT216600.0%

Forward Rev Growth

FHTX7.3%

VTVT-97.3%

Gross Margin (TTM)

FHTX0.0%

VTVT0.0%

Operating Margin (TTM)

FHTX0.0%

VTVT63.1%

EBITDA Margin (TTM)

FHTX-180.6%

VTVT-25.1%

Net Margin (TTM)

FHTX-175.8%

VTVT-12.9%

FCF Margin (TTM)

FHTX-229.4%

VTVT-45.5%

Net Income (TTM)

FHTX$-65M

VTVT$-5M

FCF (TTM)

FHTX$-84M

VTVT$-17M

EPS (TTM)

FHTX-$0.91

VTVT-$0.38

ROE (TTM)

FHTX-30161.0%

VTVT-627.0%

ROA (TTM)

FHTX-3117.0%

VTVT-506.0%

ROIC (TTM)

FHTX-30161.0%

VTVT-626.0%

Cash

FHTX$68M

VTVT$87M

Debt

FHTX$0

VTVT$0

Net Cash/Debt

FHTX$68M

VTVT$87M

Current Ratio (TTM)

FHTX3.36x

VTVT12.48x

Quick Ratio (TTM)

FHTX3.31x

VTVT12.42x

Debt/Equity (TTM)

FHTX0.00x

VTVT0.00x

Debt/Assets (TTM)

FHTX0.0%

VTVT0.0%

Interest Coverage (TTM)

FHTXN/A

VTVTN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

VTVT0.00x

Beta

FHTX3.13

VTVT0.23

52W Performance

FHTX-55.6%

VTVT38.3%

YTD Performance

FHTX-61.5%

VTVT-21.3%

% from 52W High

FHTX-73.7%

VTVT-29.1%

% from 52W Low

FHTX11.7%

VTVT59.9%

Asset Turnover (TTM)

FHTX0.18x

VTVT0.37x

FCF Yield (TTM)

FHTX-71.8%

VTVT-13.6%

Earnings Yield (TTM)

FHTX-55.0%

VTVT-3.9%

Dividend Yield (TTM)

FHTXN/A

VTVTN/A

Rule of 40

FHTX-177.4

VTVT216,554.5

EV/GP/RG

FHTXN/A

VTVTN/A

Ticker research

View FHTX research View VTVT research

Metric	FHTX Foghorn Therapeutics Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$117M	$123M
Enterprise Value	$49M	$36M
Price	$2.00	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	3.33x
EV/Sales	1.34x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	N/A
Revenue & Growth
Revenue (TTM)	$37M	$37M
Revenue Growth (YoY)	52.0%	216600.0%
Forward Rev Growth	7.3%	-97.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-180.6%	-25.1%
Net Margin (TTM)	-175.8%	-12.9%
FCF Margin (TTM)	-229.4%	-45.5%
Net Income (TTM)	$-65M	$-5M
FCF (TTM)	$-84M	$-17M
EPS (TTM)	-$0.91	-$0.38
ROE (TTM)	-30161.0%	-627.0%
ROA (TTM)	-3117.0%	-506.0%
ROIC (TTM)	-30161.0%	-626.0%
Financial Health
Cash	$68M	$87M
Debt	$0	$0
Net Cash/Debt	$68M	$87M
Current Ratio (TTM)	3.36x	12.48x
Quick Ratio (TTM)	3.31x	12.42x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	0.23
52W Performance	-55.6%	38.3%
YTD Performance	-61.5%	-21.3%
% from 52W High	-73.7%	-29.1%
% from 52W Low	11.7%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.37x
FCF Yield (TTM)	-71.8%	-13.6%
Earnings Yield (TTM)	-55.0%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-177.4	216,554.5
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View VTVT research

Valuation

P/S Ratio

FHTX

3.20x

VTVT

3.33x

EV/FCF

VTVT

-2.16x

FHTX

-0.59x

Growth & revenue

Revenue Growth TTM

VTVT

216600.0%

FHTX

52.0%

Forward Revenue Growth

FHTX

7.3%

VTVT

-97.3%

Profitability & performance

Gross Margin

FHTX

0.0%

VTVT

0.0%

ROE

VTVT

-627.0%

FHTX

-30161.0%

FCF Yield %

VTVT

-13.6%

FHTX

-71.8%

52-Week Performance

VTVT

38.3%

FHTX

-55.6%

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

VTVT

vTv Therapeutics Inc

Market Cap

FHTX$117M

VTVT$123M

Enterprise Value

FHTX$49M

VTVT$36M

Price

FHTX$2.00

VTVT$31.18

P/E Ratio

FHTXN/A

VTVTN/A

P/S Ratio

FHTX3.20x

VTVT3.33x

EV/Sales

FHTX1.34x

VTVT0.98x

EV/EBITDA

FHTX0.00x

VTVT0.00x

P/B Ratio

FHTX1,199.58x

VTVT1.53x

P/FCF Ratio

FHTXN/A

VTVTN/A

EV/FCF

FHTX-0.59x

VTVT-2.16x

PEG Ratio

FHTXN/A

VTVTN/A

Forward P/E (NTM)

FHTXN/A

VTVTN/A

Forward P/S (NTM)

FHTX4.04x

VTVTN/A

Revenue (TTM)

FHTX$37M

VTVT$37M

Revenue Growth (YoY)

FHTX52.0%

VTVT216600.0%

Forward Rev Growth

FHTX7.3%

VTVT-97.3%

Gross Margin (TTM)

FHTX0.0%

VTVT0.0%

Operating Margin (TTM)

FHTX0.0%

VTVT63.1%

EBITDA Margin (TTM)

FHTX-180.6%

VTVT-25.1%

Net Margin (TTM)

FHTX-175.8%

VTVT-12.9%

FCF Margin (TTM)

FHTX-229.4%

VTVT-45.5%

Net Income (TTM)

FHTX$-65M

VTVT$-5M

FCF (TTM)

FHTX$-84M

VTVT$-17M

EPS (TTM)

FHTX-$0.91

VTVT-$0.38

ROE (TTM)

FHTX-30161.0%

VTVT-627.0%

ROA (TTM)

FHTX-3117.0%

VTVT-506.0%

ROIC (TTM)

FHTX-30161.0%

VTVT-626.0%

Cash

FHTX$68M

VTVT$87M

Debt

FHTX$0

VTVT$0

Net Cash/Debt

FHTX$68M

VTVT$87M

Current Ratio (TTM)

FHTX3.36x

VTVT12.48x

Quick Ratio (TTM)

FHTX3.31x

VTVT12.42x

Debt/Equity (TTM)

FHTX0.00x

VTVT0.00x

Debt/Assets (TTM)

FHTX0.0%

VTVT0.0%

Interest Coverage (TTM)

FHTXN/A

VTVTN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

VTVT0.00x

Beta

FHTX3.13

VTVT0.23

52W Performance

FHTX-55.6%

VTVT38.3%

YTD Performance

FHTX-61.5%

VTVT-21.3%

% from 52W High

FHTX-73.7%

VTVT-29.1%

% from 52W Low

FHTX11.7%

VTVT59.9%

Asset Turnover (TTM)

FHTX0.18x

VTVT0.37x

FCF Yield (TTM)

FHTX-71.8%

VTVT-13.6%

Earnings Yield (TTM)

FHTX-55.0%

VTVT-3.9%

Dividend Yield (TTM)

FHTXN/A

VTVTN/A

Rule of 40

FHTX-177.4

VTVT216,554.5

EV/GP/RG

FHTXN/A

VTVTN/A

Ticker research

View FHTX research View VTVT research

Metric	FHTX Foghorn Therapeutics Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$117M	$123M
Enterprise Value	$49M	$36M
Price	$2.00	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	3.33x
EV/Sales	1.34x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	N/A
Revenue & Growth
Revenue (TTM)	$37M	$37M
Revenue Growth (YoY)	52.0%	216600.0%
Forward Rev Growth	7.3%	-97.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-180.6%	-25.1%
Net Margin (TTM)	-175.8%	-12.9%
FCF Margin (TTM)	-229.4%	-45.5%
Net Income (TTM)	$-65M	$-5M
FCF (TTM)	$-84M	$-17M
EPS (TTM)	-$0.91	-$0.38
ROE (TTM)	-30161.0%	-627.0%
ROA (TTM)	-3117.0%	-506.0%
ROIC (TTM)	-30161.0%	-626.0%
Financial Health
Cash	$68M	$87M
Debt	$0	$0
Net Cash/Debt	$68M	$87M
Current Ratio (TTM)	3.36x	12.48x
Quick Ratio (TTM)	3.31x	12.42x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	0.23
52W Performance	-55.6%	38.3%
YTD Performance	-61.5%	-21.3%
% from 52W High	-73.7%	-29.1%
% from 52W Low	11.7%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.37x
FCF Yield (TTM)	-71.8%	-13.6%
Earnings Yield (TTM)	-55.0%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-177.4	216,554.5
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View VTVT research